Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is liposarcoma?
Liposarcoma is a soft-tissue sarcoma — a cancer that begins in connective tissue rather than in an organ lining — that arises from the body's fat cells. It is one of the most common soft-tissue sarcomas in adults. Despite starting in fat, a liposarcoma is not a harmless fatty lump; it is a true cancer that grows, invades nearby tissue, and in its higher-grade forms can spread. Liposarcomas appear in two main settings. In an arm or leg, they show up as a deep, usually painless mass that grows slowly over months. Deep in the back of the abdomen (the retroperitoneum), they can grow very large before causing any symptoms, because there is room there for a tumor to expand quietly until it presses on the kidney, bowel, or other organs. Because these tumors can be mistaken for an ordinary fatty growth (a lipoma), any deep soft-tissue mass that is larger than a few centimeters, growing, or located deep rather than just under the skin should be evaluated by imaging and a biopsy at a sarcoma center rather than simply removed and assumed to be benign. Liposarcoma is really a family of subtypes that behave very differently — some are slow-growing and rarely spread, while others are aggressive and high-grade. Identifying the exact subtype is one of the most important steps, because it determines how the tumor is treated and how closely it must be watched. The cornerstone of treatment is surgery to remove the tumor completely with a margin of healthy tissue; radiation is frequently combined with surgery to treat the microscopic disease that extends beyond the visible mass, and to make a complete, organ- or limb-preserving removal more achievable.
The main types
Doctors group liposarcoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Well-differentiated liposarcoma (atypical lipomatous tumor) | The most common and least aggressive form — it grows slowly and almost never spreads, but it can come back where it started, so complete removal and follow-up matter. In a limb it is often called an atypical lipomatous tumor. |
| Dedifferentiated liposarcoma | A higher-grade tumor, often found deep in the abdomen, where an aggressive area develops within or alongside a well-differentiated tumor; it can recur and spread, so it is treated more intensively. |
| Myxoid / round-cell liposarcoma | Usually arises in the limbs of younger adults; it is notably sensitive to radiation. Unlike most sarcomas it can spread to unusual sites such as other fatty areas, the spine, and bone, so imaging looks beyond the lungs. |
| Pleomorphic liposarcoma | The rarest and most aggressive subtype, high-grade and able to spread to the lungs; treated with surgery and radiation, with chemotherapy considered in higher-risk cases. |
Staging, in plain terms
Liposarcoma is staged with the soft-tissue sarcoma TNM system, but two pieces of information matter just as much as the stage number: the grade and the subtype. Grade describes how aggressive the cells look under the microscope and how quickly the tumor is likely to grow and spread — a well-differentiated liposarcoma is low-grade and rarely spreads, while pleomorphic and dedifferentiated tumors are high-grade and carry more risk. The T category reflects the size and depth of the tumor; larger and deeper tumors are higher T. The N category notes lymph-node involvement, which is uncommon for liposarcoma, and the M category notes distant spread. Where the cancer can spread depends on subtype: high-grade tumors travel most often to the lungs, so a CT scan of the chest is standard, while myxoid/round-cell liposarcoma can spread to unusual sites such as other fat-containing areas, the spine, and bone, prompting additional imaging. In practice, the questions that shape treatment are: what subtype is it, what is its grade, how big is it and where does it sit relative to organs, nerves, and blood vessels, and has it spread. Because location matters so much, a retroperitoneal liposarcoma (deep in the abdomen) is approached differently from one in a limb — in the abdomen, complete surgical removal is the priority and nearby organs limit how much radiation can be given, while in a limb the goal is to cure the cancer and keep the limb working.
| Soft-tissue sarcoma TNM with grade — tumor size and depth (T), lymph nodes (N), distant spread (M), and the tumor grade, which is central; the specific subtype also strongly guides treatment | What it generally means |
|---|---|
| Low-grade, localized (e.g. well-differentiated) | A slow-growing tumor confined to its site that rarely spreads; treated mainly with complete surgery, with long-term follow-up because it can return locally. |
| High-grade, localized, smaller | A more aggressive tumor still confined to its site; treated with surgery and radiation to control microscopic disease and lower the chance of recurrence. |
| High-grade, localized, larger or deep | A big or deep high-grade tumor — common in the retroperitoneum; treated with surgery, radiation where it can be given safely, and chemotherapy considered in selected cases. |
| Metastatic | Cancer that has spread — to the lungs for most high-grade types, or to fat, spine, and bone for myxoid/round-cell tumors; treated with systemic therapy, with surgery or focused radiation for limited deposits. |
The standard of care
Liposarcoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical removal
Removing the tumor with a margin of healthy tissue is the central treatment; in the abdomen this may include removing an adjacent organ to achieve a complete excision, and in a limb the goal is to preserve the limb and its function.
Radiation therapy (with surgery)
Given before or after surgery to treat the microscopic disease that extends beyond the visible tumor; it allows smaller, function-preserving operations and lowers the chance of the cancer returning locally — and myxoid liposarcoma is especially responsive to it.
Chemotherapy (selected cases)
Considered for large, high-grade tumors at higher risk of spreading and used for disease that has spread; some subtypes, including myxoid/round-cell, respond better than others.
Subtype and grade diagnosis
Expert pathology — including molecular tests for the characteristic gene changes of each subtype — is essential, because the subtype and grade determine how aggressively the tumor is treated and where it might spread.
Sarcoma specialty center care
Treatment at a center with a dedicated sarcoma team gives the best chance of a complete first operation, the right use of radiation, and limb or organ preservation.
How radiation treatment works
Radiation therapy treats liposarcoma by delivering focused beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. It is a frequent partner to surgery because of the way these tumors grow: rather than staying neatly within the visible mass, soft-tissue sarcomas push microscopic fingers of tumor into the surrounding fat and connective tissue beyond what can be seen or felt. If only the visible tumor were removed, those microscopic extensions could be left behind and seed a recurrence. Radiation treats a wider zone around the tumor, sterilizing that microscopic disease so the operation can be smaller and more likely to preserve the limb or spare nearby organs, and so the cancer is far less likely to return locally. Radiation can be given before or after surgery. Before surgery, it uses a smaller treatment area and a lower dose, can shrink certain tumors — myxoid liposarcoma is particularly responsive and often shrinks substantially — and can make a complete, function-preserving removal more achievable. After surgery, radiation treats the tumor bed at a higher dose over a larger area when preoperative radiation wasn't given. The choice depends on the tumor's subtype, size, location, and the surgical plan. Subtype matters a great deal: myxoid/round-cell liposarcoma is among the most radiation-sensitive of the sarcomas, so radiation plays a especially valuable role there, while well-differentiated tumors are managed mainly by surgery with radiation reserved for situations where complete removal is difficult. Modern techniques such as intensity-modulated radiation shape the dose tightly around the target, which is especially important in the abdomen, where the kidney, bowel, and other organs sit close to the tumor and limit how much radiation can be given. Radiation also has a role beyond the original site: when liposarcoma spreads to a limited number of spots — the lungs for high-grade types, or the spine and bone for myxoid disease — focused high-dose radiation (stereotactic body radiation) can ablate those deposits and provide durable control without surgery.
The main ways radiation is delivered for liposarcoma:
Preoperative (neoadjuvant) radiation
Radiation given before surgery treats the rim of microscopic disease, can shrink certain tumors (myxoid liposarcoma often shrinks markedly), and uses a smaller field and lower dose, making a complete, function-preserving removal more achievable.
Postoperative (adjuvant) radiation
Radiation to the tumor bed after surgery, used when preoperative radiation wasn't given, sterilizes microscopic disease left behind and lowers the chance of local recurrence, at a higher dose over a larger area.
Intensity-modulated radiation (IMRT)
Shaping the beams tightly around the target spares surrounding muscle, bowel, kidney, and other organs — particularly important for tumors deep in the abdomen and for preserving limb function.
Stereotactic body radiation (SBRT) for metastases
Focused, high-dose radiation can ablate a limited number of metastases — in the lungs, or in the spine and bone for myxoid disease — providing durable control without surgery.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Myxoid liposarcoma is especially sensitive to radiation: Studies show myxoid/round-cell liposarcomas often shrink markedly with preoperative radiation, allowing smaller operations and excellent local control — making radiation a particularly powerful tool for this subtype.[1]
Myxoid liposarcoma radiosensitivity studies
Preoperative versus postoperative radiation for limb sarcomas: Randomized data show preoperative radiation uses a smaller field and lower dose with better long-term limb function but more wound-healing issues, while postoperative radiation has fewer wound problems but more late stiffness — guiding individualized timing.[2]
Pre- versus post-operative radiotherapy randomized trial (extremity sarcoma)
Radiation for retroperitoneal sarcoma: Trials of preoperative radiation for sarcomas deep in the abdomen have refined which patients benefit, with histology-tailored approaches suggesting selected liposarcomas gain better local control when radiation is added to complete surgery.[3]
Retroperitoneal sarcoma radiotherapy trials (e.g. STRASS)
Common questions
Is a liposarcoma the same as a fatty lump (lipoma)? No. A lipoma is a common, harmless fatty growth, while a liposarcoma is a true cancer that arises from fat cells and can grow into nearby tissue and, in its higher-grade forms, spread. They can look similar at first, which is exactly why a deep soft-tissue mass that is larger than a few centimeters, growing, or located deep rather than just under the skin should be imaged and biopsied at a sarcoma center rather than simply removed as if it were a lipoma.
Why does the subtype of liposarcoma matter so much? Because liposarcoma is really a family of tumors that behave very differently. A well-differentiated liposarcoma grows slowly and almost never spreads, so it is managed mainly with surgery and follow-up. A myxoid/round-cell tumor is very sensitive to radiation but can spread to unusual sites like the spine and other fatty areas. A pleomorphic or dedifferentiated tumor is high-grade and more likely to spread to the lungs. Knowing the exact subtype — confirmed by expert pathology and molecular testing — tells the team how aggressively to treat, where to look for spread, and how valuable radiation will be.
Will I need radiation if the surgeon removes the whole tumor? Often yes, especially for higher-grade tumors or when a complete margin is hard to achieve. Soft-tissue sarcomas send microscopic fingers of tumor beyond the visible mass, and radiation treats that wider zone so the cancer is less likely to return locally and the operation can be smaller and more tissue- or organ-preserving. For low-grade, well-differentiated tumors that are removed completely, radiation may not be needed and surgery with follow-up may be enough. The decision depends on subtype, grade, size, location, and the surgical margins.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Myxoid liposarcoma radiosensitivity studies (no indexed identifier — see your care team) ↩
- Pre- versus post-operative radiotherapy randomized trial (extremity sarcoma) (no indexed identifier — see your care team) ↩
- Retroperitoneal sarcoma radiotherapy trials (e.g. STRASS) (no indexed identifier — see your care team) ↩